Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-21-045373

President and CEO acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Tesi Raymond Joseph · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-25 Exercise or conversion : show line 1 in the form +30,000 $3.91 $117,300 1,524,433 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-25 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −30,000 270,000 D
Loading xslF345X03/ownership.xml…